A new analysis in Nature Medicine finds that China's rapid growth in clinical trial capacity has been concentrated in elite institutions, raising questions about whether the expansion will improve equitable access to biomedical innovation for patients across the country.
Clinical Trial Expansion in China Concentrated in Top-Tier Hospitals, Raising Equity Concerns
A new analysis in Nature Medicine finds that China's rapid growth in clinical trial capacity has been concentrated in elite institutions, raising questions about whether the expansion will improve equitable access to biomedical innovation for patients across the country.
Clinical trial · Wikimedia — licence per file · rights
This item was produced with AI assistance under the editorial responsibility of Haydamax OÜ.
Monitoring item. The full text is not distributed. Extract and source below.